Artivion | CRY - Capitale Sociale E Riserve

Prezzo Delle Azioni
35.29
Cambio Giornaliero
-1.10 -3.02%
Mensile
-8.46%
Annuale
45.53%
Q1 Previsione
35.04




Capitale Sociale E Riserve Cambiamento Data
Abbott USD 52.13B 1.3B 2025-12
Accuray USD 61.87M 19.3M 2025-09
AngioDynamics USD 176.33M 2.52M 2025-09
Artivion USD 448.23M 9.54M 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Inogen USD 197.18M 2.32M 2025-09
Integra LifeSciences USD 1.04B 5.89M 2025-12
J&J USD 78.47B 0 2025-09
Mesa Laboratories USD 186.69M 8.22M 2025-12
Orthofix International USD 450.04M 7.55M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
ResMed USD 6.32B 199.61M 2025-12
Stryker USD 21.78B 594M 2025-09
Surmodics USD 118.9M 753K 2024-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Terumo JPY 1.52T 84.79B 2025-12
Trinity Biotech USD -54.72M 5.18M 2025-09